Skip to main content

The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines.

Publication ,  Journal Article
Thanassoulis, G; Pencina, MJ; Sniderman, AD
Published in: JAMA Cardiol
November 1, 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Cardiol

DOI

EISSN

2380-6591

Publication Date

November 1, 2017

Volume

2

Issue

11

Start / End Page

1175 / 1176

Location

United States

Related Subject Headings

  • United States
  • Smoking Cessation
  • Risk Assessment
  • Practice Guidelines as Topic
  • Numbers Needed To Treat
  • Hypertension
  • Hypercholesterolemia
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Cholesterol, LDL
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thanassoulis, G., Pencina, M. J., & Sniderman, A. D. (2017). The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines. JAMA Cardiol, 2(11), 1175–1176. https://doi.org/10.1001/jamacardio.2017.2543
Thanassoulis, George, Michael J. Pencina, and Allan D. Sniderman. “The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines.JAMA Cardiol 2, no. 11 (November 1, 2017): 1175–76. https://doi.org/10.1001/jamacardio.2017.2543.
Thanassoulis G, Pencina MJ, Sniderman AD. The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines. JAMA Cardiol. 2017 Nov 1;2(11):1175–6.
Thanassoulis, George, et al. “The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines.JAMA Cardiol, vol. 2, no. 11, Nov. 2017, pp. 1175–76. Pubmed, doi:10.1001/jamacardio.2017.2543.
Thanassoulis G, Pencina MJ, Sniderman AD. The Benefit Model for Prevention of Cardiovascular Disease: An Opportunity to Harmonize Guidelines. JAMA Cardiol. 2017 Nov 1;2(11):1175–1176.

Published In

JAMA Cardiol

DOI

EISSN

2380-6591

Publication Date

November 1, 2017

Volume

2

Issue

11

Start / End Page

1175 / 1176

Location

United States

Related Subject Headings

  • United States
  • Smoking Cessation
  • Risk Assessment
  • Practice Guidelines as Topic
  • Numbers Needed To Treat
  • Hypertension
  • Hypercholesterolemia
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Cholesterol, LDL